Position in DYN
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$3,448,546
+$1,222,266 QoQ
Shares Held
155,270
+36.4% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#86
of 245 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AXXCESS WEALTH MANAGEMENT, LLC holds $9,457,652 across 14 Biotechnology names. DYN ranks #1 (36.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DYN |
Dyne Therapeutics, Inc.
This page
|
155,270 | $3,448,546 | |
| 2 | ORKA |
Oruka Therapeutics, Inc.
|
14,515 | $1,381,392 | |
| 3 | ASND |
Ascendis Pharma A/S
|
3,842 | $1,024,738 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
14,114 | $769,777 | |
| 5 | SLS |
SELLAS Life Sciences Group, Inc.
|
41,373 | $610,665 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,074 | $533,488 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
6,269 | $510,986 | |
| 8 | NTLA |
Intellia Therapeutics, Inc.
|
22,707 | $384,202 |
All Filings in DYN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,448,546 | 155,270 | Shares | Sole | 2026-07-28 | |
| 2025-12-31 | $2,226,280 | 113,818 | Shares | Sole | 2026-02-19 | |
| No filing history on record for this holder in this stock. | ||||||